https://biotechmorning.com/news/biocryst-kills-internal-drug-discovery Biotech Morning en 2026-08-15T14:18:45.457Z BioCryst Just Killed Its Own Lab. Here's Why That Might Be Brilliant. https://biotechmorning.com/news/fibrx-therapeutics-skye-redx-merger-fibrosis Biotech Morning en 2026-08-15T14:17:59.537Z Two Struggling Biotechs Just Fused Into a $125M Bet on a Disease Nobody Can Cure https://biotechmorning.com/news/epicrispr-epigenetic-editing-fshd-milestone Biotech Morning en 2026-08-15T14:17:12.926Z The Gene Therapy That Doesn't Actually Edit Your Genes https://biotechmorning.com/news/ai-designed-parkinsons-drug-clinical-trials Biotech Morning en 2026-08-15T14:16:25.296Z An AI Just Designed a Parkinson's Drug. Now It's Heading Into Humans. https://biotechmorning.com/news/zymeworks-theravance-acquisition-strategy Biotech Morning en 2026-08-15T14:15:39.811Z Zymeworks Just Bought a Lung Drug Company. The Reason Why Is Brilliant. https://biotechmorning.com/news/lilly-750m-resilience-kwikpen-glp1-manufacturing Biotech Morning en 2026-08-15T14:14:51.707Z Lilly's $750M Bet That the Real GLP-1 War Is Fought in Factories https://biotechmorning.com/news/cdc-director-erica-schwartz-confirmed Biotech Morning en 2026-08-15T14:14:05.052Z The CDC Finally Has a Boss Again. Now Comes the Hard Part. https://biotechmorning.com/news/first-orexin-drug-narcolepsy-fda-approval Biotech Morning en 2026-08-15T14:13:25.826Z The First Drug That Tackles Narcolepsy at Its Root Just Got the Green Light https://biotechmorning.com/news/moderna-mflusiva-mrna-flu-vaccine-fda-approval Biotech Morning en 2026-08-15T14:12:40.319Z Moderna Just Proved mRNA Isn't a One-Hit Wonder https://biotechmorning.com/news/zipalertinib-second-phase-3-win-egfr-lung-cancer Biotech Morning en 2026-08-14T14:17:52.041Z The Lung Cancer Drug Nobody Saw Coming Just Won Again https://biotechmorning.com/news/ptc-sangamo-fabry-gene-therapy-bankruptcy-auction Biotech Morning en 2026-08-14T14:17:06.196Z PTC Just Bought a Gene Therapy Out of Bankruptcy. It Might Be Brilliant. https://biotechmorning.com/news/sarepta-gene-therapy-nightmare Biotech Morning en 2026-08-14T14:16:14.513Z Sarepta's Gene Therapy Dream Is Turning Into a Nightmare https://biotechmorning.com/news/first-celmod-therapy-fda-approval-iberdomide Biotech Morning en 2026-08-14T14:15:28.901Z The Drug Class That Didn't Exist Until Yesterday https://biotechmorning.com/news/uk-250-million-life-sciences-rd-site Biotech Morning en 2026-08-14T14:14:39.043Z The UK Just Bet £250 Million It Can Out-Science Everyone https://biotechmorning.com/news/lantheus-mk-6240-tau-pet-alzheimers-fda-decision Biotech Morning en 2026-08-14T14:13:59.836Z Alzheimer's Has a Seeing Problem. This Brain Scan Could Fix It. https://biotechmorning.com/news/lilly-449-gambit-zepbound-black-market Biotech Morning en 2026-08-14T14:13:19.009Z Lilly's $449 Gambit to Kill the Zepbound Black Market https://biotechmorning.com/news/lyme-disease-vaccine-back-from-dead Biotech Morning en 2026-08-14T14:12:31.438Z The Vaccine That Got Killed by Fear Is Back From the Dead